Justin Kline to Proto-Oncogene Proteins c-bcl-2
This is a "connection" page, showing publications Justin Kline has written about Proto-Oncogene Proteins c-bcl-2.
Connection Strength
0.345
-
Therapeutic targeting of BCL-2 during CART cell production augments potency through non-apoptotic adaptive changes. Signal Transduct Target Ther. 2026 Apr 27; 11(1).
Score: 0.215
-
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
Score: 0.130